Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15276 - 15300 of 15305 in total

Vestipitant

Vestipitant has been investigated for the treatment of Tinnitus.
Investigational

(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine

Experimental

[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone

Experimental

Albaconazole

Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational

Oxyfedrine

Experimental

P-Nitrophenol

Experimental

3-(4-nitrophenyl)-1H-pyrazole

Experimental

7-Nitroindazole-2-Carboxamidine

Experimental

5-Nitroindazole

Experimental

2-[1-METHYLHEXYL]-4,6-DINITROPHENOL

Experimental

(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine

Experimental

6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE

Experimental

Trifluperidol

Experimental

(2S,3R,4S,5S)-3,4-Dihydroxy-2-[(methylsulfanyl)methyl]-5-(4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidinium

Experimental

1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE

Experimental

4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE

Experimental

Tozadenant

Tozadenant has been investigated for the basic science of Cocaine Dependence.
Investigational

Lofepramine

Experimental

3,5-Dinitrocatechol

Experimental

Pyrrolnitrin

Experimental

ANA971

ANA971, an orally administered prodrug of isatoribine. Isatoribine is a nucleoside analog in development for the treatment of chronic hepatitis C virus (HCV) infection. ANA971 is a prodrug designed to improve the oral bioavailability of isatoribine. ANA971 resulted in higher levels of isatoribine in the blood than were present after...
Investigational

Etonitazene

Experimental
Illicit

ETC-1001

ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational

Denibulin

Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational

4-Nitrocatechol

Experimental
Displaying drugs 15276 - 15300 of 15305 in total